Free Trial

Herbalife Ltd. (NYSE:HLF) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Herbalife logo with Retail/Wholesale background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 72.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 168,209 shares of the company's stock after buying an additional 70,498 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.17% of Herbalife worth $1,209,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in HLF. nVerses Capital LLC increased its holdings in shares of Herbalife by 240.0% in the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company's stock valued at $53,000 after acquiring an additional 3,600 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new position in Herbalife in the third quarter valued at approximately $78,000. Van ECK Associates Corp increased its stake in Herbalife by 10.3% in the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company's stock valued at $90,000 after purchasing an additional 808 shares during the last quarter. Prospera Financial Services Inc acquired a new stake in Herbalife during the third quarter worth approximately $154,000. Finally, Intech Investment Management LLC acquired a new stake in Herbalife during the third quarter worth approximately $199,000.

Wall Street Analyst Weigh In

A number of research analysts recently commented on HLF shares. StockNews.com raised shares of Herbalife from a "hold" rating to a "buy" rating in a research report on Monday, November 4th. DA Davidson dropped their price objective on Herbalife from $13.00 to $7.50 and set a "neutral" rating on the stock in a report on Thursday, October 31st. Citigroup cut their target price on Herbalife from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Mizuho upped their target price on Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research report on Friday, November 1st. Finally, B. Riley cut their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Herbalife has a consensus rating of "Hold" and a consensus target price of $9.90.

View Our Latest Stock Analysis on HLF

Herbalife Trading Down 0.3 %

Shares of HLF traded down $0.02 during mid-day trading on Wednesday, hitting $7.10. 2,851,712 shares of the company's stock were exchanged, compared to its average volume of 2,165,398. The firm has a market capitalization of $715.62 million, a P/E ratio of 8.35, a P/E/G ratio of 0.27 and a beta of 1.17. Herbalife Ltd. has a fifty-two week low of $6.59 and a fifty-two week high of $15.66. The business's 50 day moving average is $7.65 and its two-hundred day moving average is $8.84.

Herbalife (NYSE:HLF - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.38. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.23 billion. On average, equities research analysts forecast that Herbalife Ltd. will post 1.51 earnings per share for the current year.

Herbalife Company Profile

(Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Read More

Institutional Ownership by Quarter for Herbalife (NYSE:HLF)

→ Most People Are Dead Wrong. (From Brownstone Research) (Ad)

Should you invest $1,000 in Herbalife right now?

Before you consider Herbalife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.

While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines